• 1
    Blue ML, Daley JF, Levine H, Schlossman SF. Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. J Immunol 1985; 134:2281.
  • 2
    Schlesinger I, Rabinowitz R, Brenner T, Abramsky O, Schlesinger M. Changes in lymphocyte subsets in myasthenia gravis: correlation with level of antibodies to acetylcholine receptor and age of patient. Neurology 1992; 42:2153.
  • 3
    Ortolani C, Forti E, Radin E, Cibin R, Cossarizza A. Cytofluorimetric identification of two populations of double positive (CD4+,CD8+) T lymphocytes in human peripheral blood. Biochem Biophys Res Commun 1993; 191:601.DOI: 10.1006/bbrc.1993.1260
  • 4
    Sala P, Tonutti E, Feruglio C, Florian F, Colombatti A. Persistent expansions of CD4+ CD8+ peripheral blood T cells. Blood 1993; 82:1546.
  • 5
    Kitchen SG, Korin YD, Roth MD, Landay A, Zack JA. Costimulation of naive CD8 (+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J Virol 1998; 72:9054.
  • 6
    Flamand L, Crowley RW, Lusso P, Colombini-Hatch S, Margolis DM, Gallo RC. Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. Proc Natl Acad Sci USA 1998; 95:3111.DOI: 10.1073/pnas.95.6.3111
  • 7
    Yang LP, Riley JL, Carroll RG et al. Productive infection of neonatal CD8+ T lymphocytes by HIV-1. J Exp Med 1998; 187:1139.
  • 8
    Laux I, Khoshnan A, Tindell C, Bae D, Zhu X, June CH, Effros RB, Nel A. Response differences between human CD4 (+) and CD8 (+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging. Clin Immunol 2000; 96:187.DOI: 10.1006/clim.2000.4902
  • 9
    Blue ML, Daley JF, Levine H, Craig KA, Schlossman SF. Biosynthesis and surface expression of T8 by peripheral blood T4+ cells in vitro. J Immunol 1986; 137:1202.
  • 10
    Zuckermann FA. Extrathymic CD4/CD8 double positive T cells. Vet Immunol Immunopathol 1999; 72:55.DOI: 10.1016/s0165-2427(99)00118-x
  • 11
    Macchi B, Graziani G, Zhang J, Mastino A. Emergence of double-positive CD4/CD8 cells from adult peripheral blood mononuclear cells infected with human T cell leukemia virus type I (HTLV-I). Cell Immunol 1993; 149:376.DOI: 10.1006/cimm.1993.1163
  • 12
    Mizuki M, Tagawa S, Machii T et al. Phenotypical heterogeneity of CD4+ CD8+ double-positive chronic T lymphoid leukemia. Leukemia 1998; 12:499.
  • 13
    Aziz KE, McCluskey PJ, Wakefield D. Phenotypic and functional abnormalities in the peripheral blood T-cells of patients with primary Sjögren's syndrome. Cytometry 1994; 18:35.
  • 14
    Matsui M, Fukuyama H, Akiguchi I, Kameyama M. Circulating CD4+ CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis. J Neurol 1989; 236:329.
  • 15
    Munschauer FE, Stewart C, Jacobs L, Kaba S, Ghorishi Z, Greenberg SJ, Cookfair D. Circulating CD3+ CD4+ CD8+ T lymphocytes in multiple sclerosis. J Clin Immunol 1993; 13:113.
  • 16
    Mizutani H, Katagiri S, Uejima K et al. T-cell abnormalities in patients with idiopathic thrombocytopenic purpura: the presence of OKT4+8+ cells. Scand J Haematol 1985; 35:233.
  • 17
    Valesini G, Pivetti-Pezzi P, Mastrandrea F, Moncada A, Cuomo M, Natali PG. Evaluation of T cell subsets in Behcet's syndrome using anti-T cell monoclonal antibodies. Clin Exp Immunol 1985; 60:55.
  • 18
    Summers KL, JLOD, Hart DN. Co-expression of the CD45RA and CD45RO antigens on T lymphocytes in chronic arthritis. Clin Exp Immunol 1994; 97:39.
  • 19
    Peakman M, Mahalingam M, Leslie RD, Vergani D. Co-expression of CD45RA (naive) and CD45R0 (memory) T-cell markers. Lancet 1994; 343:424.
  • 20
    LaSalle JM & Hafler DA. The coexpression of CD45RA and CD45RO isoforms on T cells during the S/G2/M stages of cell cycle. Cell Immunol 1991; 138:197.
  • 21
    Murali-Krishna K & Ahmed R. Cutting edge: naive T cells masquerading as memory cells. J Immunol 2000; 165:1733.
  • 22
    Coligan JE, Kruesbeek AM, Margulies DH, Shevach EM, Strober W. Current Protocols in Immunology New York: John Wiley and Sons, Inc., 1994.
  • 23
    Mack M, Kleinschmidt A, Bruhl H et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nature Med 2000; 6:769.
  • 24
    Takahashi I & Kiyono H. Gut as the largest immunologic tissue. J Parenter Enteral Nutr 1999; 23:S7.
  • 25
    Trimble LA & Lieberman J. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. Blood 1998; 91:585.
  • 26
    Weekes MP, Wills MR, Mynard K, Hicks R, Sissons JG, Carmichael AJ. Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+CD28CD8+ T-cell population. Immunology 1999; 98:443.DOI: 10.1046/j.1365-2567.1999.00901.x
  • 27
    Weekes MP, Carmichael AJ, Wills MR, Mynard K, Sissons JG. Human CD28 CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones. J Immunol 1999; 162:7569.
  • 28
    Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, Van Lier RA. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997; 186:1407.
  • 29
    Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. AIDS 2000; 14:761.
  • 30
    Valdez H, Al-Harthi L, Landay A, Lederman MM. Rationale for immune-based therapies for HIV-1 infection. J Lab Clin Med 1998; 131:197.
  • 31
    Kelleher AD, Al-Harthi L, Landay AL. Immunological effects of antiretroviral and immune therapies for HIV. AIDS 1997; 11 (Suppl. A):S149.